Maxime Dougados

Research interests

Publications

• Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

  The Lancet Respiratory Medicine · 2021 · https://doi.org/10.1016/s2213-2600(20)30556-7

• Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

  Annals of the Rheumatic Diseases · 2020 · https://doi.org/10.1136/annrheumdis-2020-218398

• Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

  JAMA Internal Medicine · 2020 · https://doi.org/10.1001/jamainternmed.2020.6820

• EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

  Annals of the Rheumatic Diseases · 2020 · https://doi.org/10.1136/annrheumdis-2020-217159

• EULAR definition of difficult-to-treat rheumatoid arthritis

  Annals of the Rheumatic Diseases · 2020 · 10.1136/annrheumdis-2020-217344

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

  Annals of the Rheumatic Diseases · 2020 · https://doi.org/10.1136/annrheumdis-2019-216655

• 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

  Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2019-215882

• Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)31946-9

• 2016 update of the EULAR recommendations for the management of early arthritis

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2016-210602

• Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2017-211734

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2016-210715

• EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209775

• Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial

  Arthritis & Rheumatology · 2014 · https://doi.org/10.1002/art.38721

• Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

  Annals of the Rheumatic Diseases · 2013 · https://doi.org/10.1136/annrheumdis-2013-203419

• Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

  Annals of the Rheumatic Diseases · 2013 · https://doi.org/10.1136/annrheumdis-2013-204231

• Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)

  Annals of the Rheumatic Diseases · 2012 · https://doi.org/10.1136/annrheumdis-2012-201766

• Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

  Annals of the Rheumatic Diseases · 2012 · https://doi.org/10.1136/annrheumdis-2012-202469

• European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

  Annals of the Rheumatic Diseases · 2011 · https://doi.org/10.1136/annrheumdis-2011-200350

• 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

  Arthritis & Rheumatism · 2010 · https://doi.org/10.1002/art.27584

• EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

  Annals of the Rheumatic Diseases · 2010 · 10.1136/ard.2010.137216

• The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

  Annals of the Rheumatic Diseases · 2009 · https://doi.org/10.1136/ard.2008.104018

• The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy

  Arthritis & Rheumatism · 1991 · https://doi.org/10.1002/art.1780341003

Current projects

No projects listed.